Isaac Manke

Insider Reports History

Entity
Individual
Location
C/O New Leaf Venture Partners, 7 Times Square, Suite 3502, New York, NY
Signature
/s/ Rogan Nunn, by power of attorney
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Isaac Manke:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Q32 Bio Inc. Director Stock Option (Right to Buy) 19K $35.3K $13.42 Feb 24, 2025 Direct
OnKure Therapeutics, Inc. Director Class A Common Stock 3.47K $9.27K $2.67 Mar 31, 2025 Direct
Reneo Pharmaceuticals, Inc. Director Stock Option (right to buy) 15.3K Oct 4, 2024 Direct

Insider Reports Filed by Isaac Manke

Symbol Company Period Transactions Value $ Form Type Date Filed Role
OKUR OnKure Therapeutics, Inc. Mar 31, 2025 1 $0 4 Apr 2, 2025 Director
QTTB Q32 Bio Inc. Jan 15, 2025 7 $0 4 Feb 27, 2025 Director
OKUR OnKure Therapeutics, Inc. Oct 4, 2024 1 $0 4 Oct 8, 2024 Director
OKUR OnKure Therapeutics, Inc. Oct 4, 2024 0 $0 3 Oct 8, 2024 Director
QTTB Q32 Bio Inc. Apr 1, 2024 1 $35.3K 4 Sep 30, 2024 Director
QTTB Homology Medicines, Inc. Mar 25, 2024 1 $0 4 Mar 27, 2024 Director
QTTB Homology Medicines, Inc. Mar 25, 2024 0 $0 3 Mar 27, 2024 Director